You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 19, October 26, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Human Babesiosis in New York State

Review of 139 Hospitalized Cases and Analysis of Prognostic Factors

Dennis J. White, PhD; John Talarico, DO; Hwa-Gan Chang, MS; Guthrie S. Birkhead, MD, MPH; Tracey Heimberger, MD; Dale L. Morse, MD, MS

Arch Intern Med. 1998;158:2149-2154.

Background  Babesiosis infections are infrequent, occur in limited geographic locations, and range from asymptomatic infection to severe illness and death.

Methods  Descriptive clinical and epidemiological information on human babesiosis cases was collated from state communicable disease reports and medical records of patients hospitalized from 1982 to 1993. Univariate and multivariate analyses were performed to determine prognostic factors associated with severe disease outcome (hospitalization ending in death, duration of hospitalization >14 days, or intensive care unit stay >2 days).

Results  Between 1982 and 1993, 139 patients were hospitalized with babesiosis in New York State. Nine patients (6.5%) died, 35 (25.2%) were admitted to the intensive care unit, and 35 (25.2%) required hospitalization for more than 14 days. Mean age at first hospitalization was 62.5 years. Sixty-two percent were male, and 91% resided in Suffolk County, Long Island. The most common symptoms were fatigue/malaise/weakness (91%), fever (91%), shaking chills (77%), and diaphoresis (69%). Past medical records showed that 52% of patients had a history of chronic disease; 12% had a history of Lyme disease; 12% had undergone a splenectomy; and 2% had undergone a blood transfusion. There was a 12- to 14-day delay between onset of symptoms and initiation of appropriate antibiotic treatment. Univariate analyses showed alkaline phosphatase levels greater than 125 U/L, white blood cell counts greater than 5x109/L, history of cardiac abnormality, history of splenectomy, presence of heart murmur, and parasitemia values of 0.04 or higher to be significantly associated with disease severity. Multiple logistic regression analyses indicated that male sex, alkaline phosphatase values greater than 125 U/L, and white blood cell counts greater than 5x109/L remained strong predictors of severe outcome.

Conclusions  Human babesiosis is a rare but debilitating and potentially fatal illness, especially in the elderly. Prompt disease diagnosis and treatment are essential but are often delayed, as seen in our series. This delay reinforces the need for enhanced public and physician education targeted toward residents and visitors to the few high-risk geographic areas where disease and Ixodes scapularis ticks are endemic. Patients presenting with certain prognostic indicators (male sex, alkaline phosphatase values >125 U/L, and white blood cell counts >5x109/L) require comprehensive and aggressive medical care to prevent further deterioration. Since babesiosis is only 1 of 3 currently recognized diseases transmitted by I scapularis ticks, primary prevention recommendations will also reduce human exposure to Lyme disease and human granulocytic ehrlichiosis.


From the Division of Infectious Disease, Wadsworth Center, New York State Department of Health (Drs White and Morse), the Bureau of Communicable Disease Control (Drs Talarico, Birkhead, and Heimberger and Ms Chang), and the Department of Epidemiology, School of Public Health, University at Albany (Drs White, Talarico, Birkhead, and Morse), Albany, NY. Dr Heimberger is now with Abbott Laboratories, Abbott Park, Ill.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A 57-Year-Old Man With Abdominal Pain, Jaundice, and a History of Blood Transfusion
Babu and Sharma
Chest 2007;132:347-350.
FULL TEXT  

Case 17-2007 -- A 25-Year-Old Woman with Relapsing Fevers and Recent Onset of Dyspnea
Stowell et al.
NEJM 2007;356:2313-2319.
FULL TEXT  

INCREASING HEALTH BURDEN OF HUMAN BABESIOSIS IN ENDEMIC SITES
KRAUSE et al.
Am J Trop Med Hyg 2003;68:431-436.
ABSTRACT | FULL TEXT  

Human Babesiosis in Japan: Epizootiologic Survey of Rodent Reservoir and Isolation of New Type of Babesia microti-Like Parasite
Tsuji et al.
J. Clin. Microbiol. 2001;39:4316-4322.
ABSTRACT | FULL TEXT  

Diversity of Babesia Infecting European Sheep Ticks (Ixodes ricinus)
Duh et al.
J. Clin. Microbiol. 2001;39:3395-3397.
ABSTRACT | FULL TEXT  

Transfusion-transmitted babesiosis in Ontario: first reported case in Canada
Kain et al.
CMAJ 2001;164:1721-1723.
ABSTRACT | FULL TEXT  

Babesiosis -- Assessing Risk Factors for Severe Disease
JWatch Infect. Diseases 1998;1998:10-10.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.